Patent-pending modified release formulation platform to meet a range of extended release profile targets.
- 8-24 Hour Release Profile
- Burst Release with Extended Release
- Delayed with Extended Release
- Tablet, Minitablet, and Capsule Dosage Forms
ProCR™ Dissolution Profiles of Three Drug Candidates